Edwards Lifesciences Earnings & Forecasts

Edwards Lifesciences (EW) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q2	Jul 23, 2026	$0.78	$0.74	5.41 %
Q1	Apr 23, 2026	$0.78	$0.73	6.85 %
Q4	Feb 10, 2026	$0.58	$0.62	-6.45 %
Q3	Oct 30, 2025	$0.67	$0.59	13.6 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q2	Jul 23, 2026	$1.74B	$1.70B	2.42 %
Q1	Apr 23, 2026	$1.65B	$1.59B	3.41 %
Q4	Feb 10, 2026	$1.57B	$1.54B	1.81 %
Q3	Oct 30, 2025	$1.55B	$1.50B	3.66 %

Edwards Lifesciences Guidance

Edwards Lifesciences (EW)은 지난 7월 23, 2026에 Q3 2026의 실적 전망을 발표했습니다. 회사는 주당순이익을 $0.71 - $0.77 범위로 전망했으며, 이는 시장 컨센서스 EPS 추정치인 $0.74보다 높은 수치입니다. Edwards Lifesciences는 또한 해당 기간의 매출을 $1.63B - $1.71B 범위로 전망했습니다.

이전 가이던스와 비교하여 Edwards Lifesciences는 매출 전망치를 이전 범위인 하향 조정됨에서 $6.6B - $6.9B로 상향 조정했습니다.

Edwards Lifesciences은 40과 10월 27, 2022 사이에 7월 23, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 6 times and lowered it 17 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$0.74	$0.73	$0.62	$0.59
Actual	$0.78	$0.78	$0.58	$0.67
Surprise	+5.41%	+6.85%	-6.45%	+13.6%
Revenue
Estimate	$1.70B	$1.59B	$1.54B	$1.50B
Actual	$1.74B	$1.65B	$1.57B	$1.55B
Surprise	+2.42%	+3.41%	+1.81%	+3.66%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$0.74	$0.71	$0.84	$0.86
Revenue
Consensus	$1.68B	$1.70B	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says

Edwards Lifesciences tops Q2 Wall Street estimates with $1.74B in revenue. EW stock jumps as analysts see continued upside ahead.

Vandana Singh

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Oil Prices Decline—Intel, Edwards Lifesciences, SAP in Focus (UPDATED)

U.S. stock futures were higher on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday's lower close.

Rishabh Mishra

American Express, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday

US stock futures mixed, focus on companies like American Express, Deckers, Verizon, Edwards Lifesciences, and HCA Healthcare for today's trading.

Avi Kapoor

PRO
Edwards Lifesciences Sees Q3 Adj EPS $0.71-$0.77 vs $0.74 Est; Sees Sales $1.630B-$1.710B vs $1.689B Est

Edwards Lifesciences (NYSE:EW) is looking for Q3 Adj EPS of $0.71-$0.77 vs $0.74 analyst estimate. sees sales of $1.630 billion-$1.710 billion vs $1.689 billion analyst estimate.

Benzinga Newsdesk

PRO
Edwards Lifesciences Affirms FY2026 Adj EPS Guidance of $2.95-$3.05 vs $3.01 Est; Raises FY2026 Sales Guidance from $6.500B-$6.900B to $6.600B-$6.900B vs $6.745B Est

Edwards Lifesciences (NYSE:EW) affirms FY2026 Adj EPS guidance from $2.95-$3.05 to $2.95-$3.05 vs $3.01 analyst estimate. Raises FY2026 sales outlook from $6.500 billion-$6.900 billion to $6.600 billion-$6.900 billion

Benzinga Newsdesk

PRO
Edwards Lifesciences Q2 Adj. EPS $0.78 Beats $0.74 Estimate, Sales $1.741B Beat $1.700B Estimate

Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.74 by 5.41 percent. This is a 16.42 percent increase over earnings of $0.67 per share from

Benzinga Newsdesk

Edwards Lifesciences Corp